HLE Glascoat Limited (HLEGLAS) Multibagger Analysis

Press Release

02 November 2026 · Order win · Unlikely · Engineering · score 28/100

Deal

Deal value₹42 Cr

Deal vs businessOrder book = ₹1,087.3 Cr (0.79x TTM revenue); Capex = ₹42-45 Cr (3.1% of TTM revenue)

Size vs own revenue0.79×

Execution period1.5 yr

Fundamental gradeC

AI projections

Revenue uplift (yr1 / steady)7.0% / 14.0%

EPS uplift22.0%

Upside base / bull / bear12.0% / 55.0% / -40.0%

Horizon18-24 months

Realized market record

Entry — next-day open—

Latest close (02 Nov 2026)₹410.3

Return since—

α vs Smallcap 250—

α vs own sectorshown once held 90+ days — Engineering median is +1.6% over 48 matured picks

Positives

Consolidated order book reached a record ₹1,087.3 Cr, establishing near-term revenue visibility across 3-4 quarters.
Q2 FY27 PAT sharply rebounded sequentially to ₹16.0 Cr from ₹2.1 Cr in Q1 FY27, showing stabilization from trough operating margins.
Order diversification into tunnel cladding via the €20.56M Fehmarnbelt contract expands revenue beyond traditional chemical process equipment.
Healthy and stable promoter shareholding at 65.64% provides alignment and operational continuity.

Risks

Excessive trailing valuation of 78.6x P/E against an engineering peer median of 35.8x creates acute derating vulnerability.
Total order backlog of ₹1,087.3 Cr is only 0.79x TTM revenue, representing less than one year of run-rate billings rather than a transformative growth catalyst.
Sub-par capital efficiency with ROCE at 12.0% alongside leverage of 0.78 D/E (₹311 Cr debt on ₹401 Cr net worth).
High sensitivity to global and domestic pharma/chemical capex cycles (79% of revenue exposure), which remain subdued.
Margin volatility from ongoing integration and initial losses at acquired European subsidiaries (Thaletec, HLE Surface Technologies).

Full AI brief

1. Executive Summary & Announcement Reality Check

On 2026-11-02, HLE Glascoat announced its Q2 FY27 results alongside a milestone consolidated order book of ₹1,087.3 crore and an approved capex of ₹42-45 crore for a heavy engineering unit at Adas, Gujarat. While headline metrics show strong sequential recovery (Q2 PAT of ₹16.0 Cr vs ₹2.1 Cr in Q1 FY27), the fundamental narrative does not support a high-probability multibagger setup.

The backlog crossing ₹1,000 Cr is primarily driven by the €20.56M (~₹190 Cr) Fehmarnbelt tunnel contract won by its German subsidiary, which was already publicly disclosed on 2026-09-08. Crucially, an order book of ₹1,087.3 Cr against a TTM revenue base of ₹1,370 Cr equates to just 0.79x TTM revenue (~9.5 months of billings). In capital goods and custom process engineering, an order book under 1.0x book-to-bill is maintenance-level backlog, not an explosive growth indicator.

2. Ramp-Aware Catalyst Financial Math

Order Book Size: ₹1,087.3 Cr.
Execution Schedule: Typically 12 to 18 months for process equipment and heavy engineering components.
Annualized Backlog Conversion: Assuming 70% of the backlog (₹761 Cr) converts in Year 1 alongside baseline flow orders (~₹700 Cr), Year 1 revenue stabilizes at ~₹1,460 Cr (+6.6% over TTM revenue of ₹1,370 Cr).
Capex Addition: The ₹42-45 Cr Adas heavy engineering capex represents ~11% of net worth (₹401 Cr). At an asset turnover of 2.0x-2.2x, it adds ₹85-100 Cr in steady-state annual revenue once fully commissioned in 24 months.
Margin & Earnings Flow-Through:
Current TTM OPM is 9.0%, down from 13.0% in FY25 due to competitive pricing and initial drag from German acquisitions.
On an incremental ₹100 Cr revenue from capex at 11% EBITDA margin, incremental EBITDA is ₹11 Cr. Less depreciation (₹3 Cr), interest on debt financing (₹2.5 Cr), and tax (25%), incremental PAT is ~₹4.1 Cr.
Base steady-state PAT: Normalizing Q2 FY27 run-rate (₹16 Cr/quarter = ₹64 Cr annualized) plus capex addition yields ~₹68-70 Cr PAT (EPS ~₹8.90-9.15 vs TTM EPS of ₹5.22).

3. Industry Context & Execution Difficulty

Industry Capital Intensity: MEDIUM. Process equipment fabrication requires substantial investments in heavy hydraulic presses, welding setups, and glass-lining furnaces, along with long working-capital holding periods (inventory and work-in-progress for custom equipment).
Execution Risk: Moderate to high. Long delivery lead times (6-15 months) expose fixed-price or competitively priced orders to steel price fluctuations and energy cost inflation.
Structural Growth: Expected industry CAGR is ~10%. While the shift toward integrated 'one-stop' filtration, drying, and glass-lined equipment benefits established players, broader chemical industry capex is experiencing cyclical softness.

4. Quality & SEPA Fundamentals Analysis

Earnings Acceleration: Weak. Q1 FY27 EPS crashed 85% YoY (₹0.40 vs ₹2.62). Q2 FY27 PAT of ₹16.0 Cr improved 14.8% YoY over Q2 FY26 (₹13.96 Cr), but standalone revenue fell 14.3% YoY and standalone PAT fell 43.4% YoY. Trailing TTM PAT of ₹41 Cr is significantly below FY25 (₹61.8 Cr) and FY26 (₹56.6 Cr).
Return Ratios: ROCE stands at 12.0%, well below the 18-20%+ threshold typical of high-quality industrial compounders.
Balance Sheet Leverage: Debt of ₹311 Cr on a net worth of ₹401 Cr results in a D/E of 0.78. Interest obligations act as an earnings drag during cyclical downshifts.
Valuation Headwind: Trailing P/E is 78.6x and P/B is 8.0x, compared to a peer median P/E of 35.8x. The stock trades at an extreme growth premium despite showing negative 12-month relative price strength (-28.5%).

5. Scenario Analysis & Valuation Targets

Base Case (18-24 Months):
Assumptions: Order book execution normalizes; revenue reaches ₹1,550 Cr; OPM stabilizes at 11.0%; PAT reaches ₹62 Cr (EPS ₹8.10). Multiple compresses from 78.6x to a still-premium 55x.
Market Cap: ₹3,410 Cr | Target Price: ₹436.8 (+6.5% to +12.0% upside).
Bull Case (18-24 Months):
Assumptions: Rapid revival in chemical/API capex; German operations reach mid-teen margins; revenue scales to ₹1,750 Cr; PAT expands to ₹88 Cr (EPS ₹11.50). Multiple sustains at 55x.
Market Cap: ₹4,840 Cr | Target Price: ₹620 (+51.0% to +55.0% upside).
Bear Case (18-24 Months):
Assumptions: Sustained chemical sector slump; German subsidiary integration losses continue; input cost inflation compresses OPM to 8.5%; PAT stays muted at ₹38 Cr (EPS ₹4.95). Multiple derates toward peer median at 40x.
Market Cap: ₹1,520 Cr | Target Price: ₹246 (-40.0% downside).

6. Verdict Rationale

HLE Glascoat is a quality niche player in glass-lined and filtration equipment, but at 78.6x TTM P/E with an order book that only covers ~0.79x annual revenue, the risk-reward profile is skewed unfavorable. It fails the quality gate on ROCE (12%) and lacks the explosive backlog multiple required to produce multibagger re-rating.

Analysis as of 2026-11-02 (price ₹410.30) · AI research, not investment advice.

FollowTelegram

Verdicts and projections on this page are produced by an AI model from HLE Glascoat Limited's public exchange filings and are not investment advice. "Return since" is measured from the opening price of the next trading day after each announcement to the latest available close, so it reflects a price an investor could actually have paid. See all analysed companies on Multibagger AI.

HLE Glascoat Limited (HLEGLAS) — Multibagger Analysis